Justin Stindt Consultants is a market access consulting firm specializing in evidence-based commercial forecasting and market modeling for the life sciences industry. Our forecasting service delivers robust sales and patient uptake estimates based on a deep analysis of market potential, adoption (uptake) curves, pricing scenarios, and real-world data. Our consulting experts build our forecasts to inform your strategy, whether you are preparing for a product launch, licensing deal, or investment due diligence. By combining the JSC forecasting analytics with market access insights, our consultants ensure that projected outcomes are realistic and aligned with payer and pricing environments.
Commercial Forecasting & Market Potential in Life Sciences
In the life sciences industry, an accurate commercial forecast is the backbone of strategic decision-making. Justin Stindt Consultants specializes in evidence-based market modeling that bridges the gap between clinical potential and financial reality. By integrating Market Access insights into our analytics, we deliver robust revenue projections that account for pricing scenarios, patient uptake, and global reimbursement dynamics.
- Patient-Centric Market Sizing: We utilize epidemiological data and treatment pathways to define the Total Addressable Market (TAM) and specific sub-populations.
- Adoption & Uptake Modeling: Our consultants build sophisticated adoption curves calibrated with analog launch data and expert feedback (physicians/payers).
- Pricing Scenario Analysis: We simulate revenue outcomes across various price points, specifically modeling US Gross-to-Net and EU List vs. Net prices to avoid common miscalculations.
Why it matters: A forecast that ignores regional market access hurdles isn’t a strategy, it’s a risk. We ensure your projections are “investor-ready” by pressure-testing every assumption against real-world data.
Developing comprehensive market forecasts for new products
Accurate forecasts begin with understanding the total addressable market for your product. We analyze epidemiological data, treatment pathways, and competitor dynamics to estimate patient populations and market potential. Our models incorporate uptake curves that project how quickly and extensively a new therapy or device will be adopted over time, reflecting factors like market penetration, competition, and treatment rates. These adoption curves are calibrated with analog launch data and expert feedback to produce realistic projections of market uptake.
Key components of our forecasting approach include:
- Market Sizing & Segmentation: Estimating total patient pools and relevant subpopulations (indications, therapy lines, etc.) to quantify market potential.
- Uptake & Adoption Modeling: Constructing detailed adoption curves that capture how providers and patients will use the product over time, based on clinical need and market factors.
- Pricing Scenario Analysis: Simulating sales outcomes under different pricing and reimbursement scenarios, showing how price and access levels affect volume and revenue.
- Evidence Integration: Leveraging real-world data, clinical trial results, analog product benchmarks, and payer research to ground each forecast in factual market dynamics.
While we have deep expertise in the EU5 (France , Germany , Italy , Spain , UK ) and US markets, our methodology can be applied to any region worldwide. Each forecast is customized to reflect local epidemiology, payer systems, and market conditions, so you can confidently expand our analysis to new markets as needed.
Scenario-based forecasting and pricing analysis
In our market access consulting firm, pricing and reimbursement assumptions are tightly integrated into forecasting. We run scenario analyses to project outcomes under various launch strategies, price points, and access conditions. For example, we might model a high-price launch versus a value-based pricing scenario to show how adoption curves and revenue differ. We also factor in regional market access realities, such as payer willingness-to-pay, international reference pricing, and coverage policies, ensuring each forecast reflects local market conditions.
By linking forecasting directly to pricing strategy, we ensure projected sales figures are both realistic and strategic. Our consultancy forecasts specifically US gross to net and list price and net prices in major EU markets rather than just extrapolating historic trends or US prices. This approach supports decision-making across pricing, reimbursement, and market access. For instance, our forecasts can identify which pricing strategy is likely to maximize return on investment or pinpoint key markets where improved access conditions could significantly boost sales. These insights are particularly valuable in due diligence and strategic planning contexts, where investors and executives need credible, evidence-based revenue projections.
Forecasting - What Sets Justin Stindt Consultants Apart?
Our forecasting team combines deep analytical skills with extensive market access expertise, delivering insights that generic forecasts cannot match. We customize every forecast to your specific product and situation, rather than using one-size-fits-all models. Our experts draw on a network of payers, clinicians, and industry specialists to validate assumptions and incorporate the latest market intelligence.
What makes our approach unique:
- Integrated Market Access Expertise: We blend commercial forecasting with payer and HTA insights, so forecasts inherently account for reimbursement and pricing realities from the start.
- Data-Driven and Evidence-Based: Every forecast is backed by data, from epidemiology and clinical evidence to analog product benchmarks and stakeholder interviews, giving you confidence in the results.
- Tailored Scenario Planning: We model multiple launch and market scenarios, including different pricing strategies, uptake speeds, and coverage timelines, so you can see a range of possible outcomes.
- Strategic Alignment with Pricing & Due Diligence: Our forecasts are designed to support your broader strategy. Whether for internal business planning, licensing negotiations, or investor reviews, our outputs tie directly into pricing and market access decisions.
Together, these elements ensure that our market access consultancy clients receive accurate, actionable forecasts that drive smarter launch strategies and investment decisions.
FAQ
1. How do you calculate market potential for a new therapy?
We begin with a granular analysis of epidemiological data to identify the eligible patient population. We then segment this market by therapy lines, disease severity, and geographic regions (US, EU5). By integrating treatment pathways and competitive dynamics, we define the realistic volume your product can capture.
2. What is the importance of "Uptake Curves" in life science forecasting?
Uptake curves project the speed of market penetration. Unlike generic models, our curves are calibrated using analog data from similar launches and qualitative insights from key opinion leaders (KOLs). This helps identify how quickly providers will adopt a new device or drug and when the peak sales will be reached. Without this, forecasts tend to overestimate early revenue, one of the most common credibility killers in investor presentations.
3. How does "Gross-to-Net" impact US market forecasting?
In the US, the gap between the list price and the actual revenue (Net) can be massive due to rebates and discounts. We specifically model US Gross-to-Net dynamics rather than simple trend extrapolation. This ensures that your financial planning reflects the actual cash flow you can expect from the American market.
4. Can forecasting help with investor due diligence?
Absolutely. Investors look for “pressure-tested” models. By providing scenario-based forecasting (Best-case, Base-case, Worst-case) that includes pricing and reimbursement risks, you demonstrate a deep understanding of the market. This transparency builds credibility and reduces the perceived risk for both investors and potential partners.
Connect with our team
Get in touch with our expert
CLIENT TESTIMONIALS
